Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA)

D. Østergaard,J. Viby-Mogensen,S. Rasmussen,M. R. Gätke,N. A. Pedersen,L. Skovgaard
DOI: https://doi.org/10.1046/j.1399-6576.2003.00243.x
2003-11-01
Acta Anaesthesiologica Scandinavica
Abstract:Background:  Mivacurium is hydrolyzed by plasma cholinesterase (pChe). The purpose of this study was to evaluate the pharmacodynamics and the pharmacokinetics of the three isomers of mivacurium in patients phenotypically heterozygous for the usual and the atypical pChe variant (UA).
What problem does this paper attempt to address?